(Q63843126)
Statements
Randomized, Double-Blind, Placebo-Controlled, Sequential Ascending Dose Study of the Clinical Activity, Safety, Tolerability and Pharmacokinetics of a Single IV Dose of REGN846 in Refractory Moderate-to-Severe Pruritus in Adult Patients With Moderate-to-Severe Atopic Dermatitis (English)
0 references
June 2012
0 references
April 2013
0 references
19
0 references
18 year
0 references
65 year
0 references